İbrahim PİRİNÇCİ, Ahmet ATEŞŞAHİN, İzzet KARAHAN

The Effects of Fenfluramine on Blood and Tissue Serotonin (5-Hydroxytryptamine) Levels in Rats

The aim of this study was to investigate the effect of fenfluramine (FEN) administered at single and repeated doses on brain, stomach and plasma serotonin (5-Hydroxytryptamine, 5-HT) levels in rats. FEN was injected intraperitoneally at single doses (1, 3 and 10 µmol kg-1) and given orally at repeated doses (1.25, 5 and 10 mg kg-1) for 21 days. The tissues and plasma samples were collected 20, 40, 80 and 160 minutes after the single dose administrations and 4 h after the last dose administration in repeated experiments. In addition, the rats treated with the dose of 1.25 mg kg-1 were maintained until 2 and 8 weeks and the tissues were taken at these times. The 5-HT levels in the tissue and plasma were measured by using high performance liquid chromatography (HPLC). The levels of brain 5-HT were decreased at the single FEN doses when compared with the control group. At the repeated experiments, although no effect was observed at the dose of 1.25 mg kg-1; decreases were determined in brain 5-HT levels at the high doses. The levels of 5-HT in the stomach were found to increase in both single and repeated administrations. Decreases in levels of plasma 5-HT were determined in all experimental groups. In conclusion, while fenfluramine was determined to decrease brain and plasma 5-HT levels generally, it increased the levels of stomach 5-HT.

Anahtar Kelimeler:

Fenfluramine, rat, brain, stomach, plasma, serotonin.

The Effects of Fenfluramine on Blood and Tissue Serotonin (5-Hydroxytryptamine) Levels in Rats

Keywords:

Fenfluramine, rat, brain, stomach, plasma, serotonin.,

PDF

___

Kema, I.P., Vries, E.G.E., Muskiet, F.A.J.: Clinical chemistry of serotonin and metabolites. J. Chromatogr. Biomed. Sci. Appl., 2000; 747: 33-48. 2. Pussard, E., Guigueno, N., Adam, O., Giudicelli, J.F.: Validation of HPLC-amperometric detection to measure 5-HT in plasma platelets whole blood and urine. Clin. Chem., 1996; 42: 1086- 1091. 3. Lovinger, D.M.: The role of 5-HT in alcohol’s effects on the brain. Cur. Separat, 1999; 18: 23-28.
Yamada, J., Sugimoto, Y., Ujikawa, M.: The 5-HT precursor 5- hydroxytryptophan elevates serum leptin levels in mice. Eur. J. Pharmacol., 1999; 383: 49-51.
MacDonald, E.J., Cavan, K.R., Smith, T.K.: Effect of acute oral doses of T-2 toxin on tissue concentrations of biogenic amines in the rat. J. Anim. Sci., 1988; 66: 434-441. 9. Russel, B.R., Laverty, R.: The effect of (R)-HA966 or ACEA 1021 on dexfenfluramine or (S)-MDMA-induced changes in temperature, activity and neurotoxicity. Pharmacol. Biochem. Behav., 2001; 68: 565-574.
Knobelman, D.A., Kung., H.F., Lucki, I.: Regulation of extracellular concentrations of 5-hydroxytryptophan in mouse striatum by 5-HT (1A) and 5-HT (1B) receptors. J. Pharmacol. Exp. Ther., 2000; 292: 1111-1117.
Baumann, M.H., Ayestas, M.A., Rothman, R.B.: Functional consequences of central 5-HT depletion produced by repeated fenfluramine administration in rats. J. Neurosci., 1998; 18: 9069-9077.
Baumann, M.H., Ayestas, M.A., Dersch, C.M., Rothman, R.B.: 1- (m-Chlorophenyl) piperazine (mCPP) dissociates in vivo 5-HT release from long-term 5-HT depletion in rat brain. Neuropsychopharmacology, 2001; 24: 492-500.
Vickers, S.P., Clifton, P.G., Dourish, C.T., Tecott, L.H.: Reduced satiating effect of d-fenfluramine in 5-HT 5-HT (2C) receptor mutant mice. Psychopharmacology, 1999; 143: 309-314.
Cheetham, S.C., Viggers, J.A., Slater, N.A., Heal, D.J.: Sibutramine does not decrease the number of 5-HT re-uptake sites in rat brain and like fluexetine protects against the deficits produced by dexfenfluramine. Neuropharmacology, 2000; 39: 2028-2035.
Costa, E., Groppetti, A., Revuelta, A.: Action of fenfluramine on monoamine stores of rat tissues. Br. J. Pharmacol., 1971; 41: 57-64.
Schwartz, D., Hernandez, L., Hoebel, B.G.: Fenfluramine administered systemically or locally increases extracellular 5-HT in the lateral hypothalamus as measured by microdialysis. Brain Res., 1989; 482: 261-270.
Kalia, M., Callaghan, J.P.O., Miller, D.B., Kramer, M.: Comparative study of fluoxetine, sibutramine, sertraline and dexfenfluramine on the morphology of serotonergic nerve terminals using 5-HT immunohistochemistry. Brain Res., 2000; 858: 92-105.
Appel, N.M., Mitchell, W.M., Contrera, J.F., De Souza, F.B.: Effects of high dose fenfluramine treatment on monoamine uptake sites in rat brain: Assessment using quantitative autoradiography. Synapse, 1990; 6: 33-44.
Caccia, S., Confalonieri. S., Bergami, A., Fracasso, C., Anelli, M., Garattini, S.: Neuropharmacological effects of low and high doses of repeated oral dexfenfluramine in rats: A comparison with fluoxetine. Pharmacol. Biochem. Behav., 1996; 57: 851-856.
Reimann, W., Schneider, F.: Induction of 5-hydroxytryptamine release by tramadol, fenfluramine and reserpine. Eur. J. Pharmacol., 1998; 349: 199-203.
McCann, U.D., Seiden, L.S., Rubin, L.J., Ricaurte, G.A.: Brain 5- HT neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine. J. Am. Med. Assoc., 1997; 278: 666-672.
Yamada, J., Sugimoto, Y., Horisaka, K.: Simultaneous determination of tryptophan and its metabolites in mouse brain by high-performance liquid chromatography with fluorometric detection. Anal. Biochem., 1983; 129: 460-463.
Stewart, C.W., Slikker, W.: Hyperthermia enhanced 5-HT (5-HT) depletion resulting from D-fenfluramine (D-FEN) exposure does not evoke a glial cell response in the central nervous system of rats. Brain Res., 1999; 839: 279-282.
Stewart, C.W., Slikker, W.: Hyperthermia enhanced 5-HT depletion resulting from D-fenfluramine exposure is preventable. Life Sci., 1999; 65: 1531-1536.
Clausing, P., Newport, G.D., Bowyer, J.F.: Fenfluramine and norfenfluramine levels in brain microdialysate, brain tissue and plasma of rats administered doses of d-fenfluramine known to deplete 5-hydroxytryptamine levels in brain. J. Pharmacol. Exp. Ther., 1998; 284: 618-624.
Kema, I.P., Schelligs, A.M.J., Meiborg, G., Hoppenbrouwers, C.J.M., Muskiet, F.A.J.: Influence of 5-HT and dopamine rich diet on platelet 5-HT content and urinary excretion of biogenic amines and their metabolites. Clin. Chem., 1992; 38: 1730-1736.
Hervig, T., Volundardottir, T., Bakken, A.M., Farstad, M.: Thrombin induced 5-HT release as an in-vitro indicator of the functional integrity of stored platelets. Clin. Chem., 1990; 36: 28-31.
Anderson, G.M., Feibel, F.C., Wetlaufer, L.A., Schlicht, K.R., Ort, S.M., Cohen, D.J.: Effect of a meal on human whole blood 5-HT. Gastroenterology, 1985; 88: 86-89.